Is PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 still in force?

Yes — PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 is currently in force.

When did PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 take effect?

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 was first recorded in 2014.

How many sections does PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 have?

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 contains 2 sections.

Where can I read the official version of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014?

The official text of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 is published at lom.agc.gov.my.

/akn/my/act/pua/2014/72

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014

The full official text, structured for quick navigation. Copy any provision or jump straight to a section.

Open source PDF

Type: P.U. (A)
Status: In force
Enacted: 2014
Sections: 2

Quick answer

About this p.u. (a)

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 is Malaysia P.U. (A), cited as P.U. (A) 72 2014, currently marked in force and first recorded in 2014.

Opening note

Preamble

PADA menjalankan kuasa yang diberikan oleh seksyen 6 Akta Racun 1952 [Akta 366], Menteri, selepas berunding dengan Lembaga Racun, membuat perintah yang berikut: Nama

Seksyen 1

Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Senarai Racun) 2014.

Seksyen 2

Pindaan Jadual Pertama

(1)

dalam Senarai Racun—

(a)

dengan memasukkan selepas butiran “Antimony; its chlorides, oxides, sulphides, antimonates, antimonites; organic compounds of antimony” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Bahagian I

Part I

Bahagian II

Part II

Exempt

Group A

Group B

Group C

Group D

“Apixaban

All preparations”;

P.U. (A) 72 3

(b)

dalam butiran “Arsenic; its organic and inorganic compounds”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Arsenic; its organic and inorganic compounds

All medicinal preparations unless exempted

Preparations other than medicinal preparations unless exempted

(1)

Cosmetic which is notified under the Control of Drugs and

Cosmetics

Regulations 1984

[P.U. (A) 223/1984] containing not more than 5 parts per million of arsenic calculated as the metal;

(2)

Product which is registered under the Control of Drugs and

Cosmetic

Regulations 1984

[P.U. (A) 223/1984] containing not more than 5 parts per million of arsenic calculated as the metal”;

(c)

dengan memasukkan selepas butiran “Atracurium; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Avanafil

All preparations”;

P.U. (A) 72 4

(d)

dengan memasukkan selepas butiran “Avoparcin” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Axitinib

All preparations”;

(e)

dalam butiran “Mercury”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Mercury

All preparations unless exempted

(1)

Cosmetic which is notified under the Control of Drugs and

Cosmetics Regulations 1984

[P.U. (A) 223/1984] containing not more than 1 part per million of mercury calculated as the metal;

(2)

Product which is registered under the Control of Drugs and

Cosmetic

Regulations 1984

[P.U. (A) 223/1984] containing not more than 0.5 part per million of mercury calculated as the metal”;

P.U. (A) 72 5

(f)

dengan memasukkan selepas butiran “Narcotic substances, the following: their isomers (whenever the existence of such isomers is possible within the specific chemical designation); their salts; their esters and ethers (whenever the existence of such esters or ethers is possible); the salts of their esters and ethers” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Natalizumab

All preparations”;

(g)

dalam butiran “Natamycin”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Natamycin

All preparations unless exempted

Natamycin when use as food additive”;

P.U. (A) 72 6

(h)

dengan memasukkan selepas butiran “Perindopril” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Pertuzumab

All preparations”;

(i)

dalam butiran “Potassium hydroxide”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

(j)

dengan memasukkan selepas butiran “Practolol; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Potassium hydroxide

12% and over unless exempted

Under 12%, accumulators, batteries or when use as food additive”;

Names

Exempt

Group A

Group B

Group C

Group D

“Pralatrexate

All preparations”;

P.U. (A) 72 7

(k)

dengan memasukkan selepas butiran “Recombinant-Methionyl Human Granulocyte-colony stimulating factor” dan butir-butir yang berhubungan dengannya butiran yang berikut:

(l)

dalam butiran “Sodium hydroxide”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Regorafenib

All preparations”;

Names

Exempt

Group A

Group B

Group C

Group D

“Sodium hydroxide

All preparations for therapeutic or diagnostic use

All preparations containing 12% and over other than those in Part I or exempted and subject to the provisions of Poisons

(Sodium Hydroxide)

Regulations,

1962

[L.N. 145/62]

Under 12%;

Sodium hydroxide when use as food additive”; dan

P.U. (A) 72 8

(m)

dengan memasukkan selepas butiran “Vecuronium; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Vemurafenib

All preparations”;dan

(2)

dalam Lampiran Senarai Racun—

(a)

dalam senarai “Antineoplastic agents and Immunosuppressants”—

(i)

dengan memasukkan selepas butiran “L-Asparaginase” butiran “Axitinib”;

(ii)

dengan memasukkan selepas butiran “Mycophenolic acid” butiran “Natalizumab”;

(iii)

dengan memasukkan selepas butiran “Penciclovir” butiran berikut:

“Pertuzumab

Pralatrexate”;

(iv)

dengan memasukkan selepas butiran “Rasburicase” butiran “Regorafenib”; dan

(v)

dengan memasukkan selepas butiran “Trofosfamide” butiran “Vemurafenib”.

(b)

dalam senarai “Vasodilators”, dengan memasukkan selepas butiran “Amyl nitrite” butiran “Avanafil”; dan

P.U. (A) 72 9

(c)

dalam senarai “Miscellaneous”, dengan memasukkan selepas butiran “Anticoagulant substances including heparin and other substances structurally derived from coumarin and phenindione unless specified elsewhere in the List”

butiran “Apixaban”.

Dibuat 11 Februari 2014

[KK(R)608(14); PN(PU2)172/XII]

DATUK SERI DR. S. SUBRAMANIAM

Menteri Kesihatan

P.U. (A) 72 10

POISONS ACT 1952

POISONS (AMENDMENT OF POISONS LIST) ORDER 2014

Opening note

Preamble

IN exercise of the powers conferred by section 6 of the Poisons Act 1952 [Act 366], the Minister, after consultation with the Poisons Board, makes the following order: Citation 1. This order may be cited as the Poisons (Amendment of Poisons List) Order 2014. Amendment of First Schedule 2. The Poisons Act 1952 is amended in the First Schedule—

(1)

in the Poisons List—

(a)

by inserting after the item “Antimony; its chlorides, oxides, sulphides, antimonates, antimonites; organic compounds of antimony” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Apixaban

All preparations”;

P.U. (A) 72 11

(b)

in the item “Arsenic; its organic and inorganic compounds”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Arsenic; its organic and inorganic compounds

All medicinal preparations unless exempted

Preparations other than medicinal preparations unless exempted

(1)

Cosmetic which is notified under the Control of Drugs and

Cosmetics Regulations 1984

[P.U. (A) 223/1984] containing not more than 5 parts per million of arsenic calculated as the metal;

(2)

Product which is registered under the Control of Drugs and

Cosmetic

Regulations 1984

[P.U. (A) 223/1984] containing not more than 5 parts per million of arsenic calculated as the metal”;

(c)

by inserting after the item “Atracurium; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Avanafil

All preparations”;

P.U. (A) 72 12

(d)

by inserting after the item “Avoparcin” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Axitinib

All preparations”;

(e)

in the item “Mercury”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Mercury

All preparations unless exempted

(1)

Cosmetic which is notified under the Control of Drugs and

Cosmetics Regulations 1984

[P.U. (A) 223/1984] containing not more than 1 part per million of mercury calculated as the metal;

(2)

Product which is registered under the Control of Drugs and

Cosmetic

Regulations 1984

[P.U. (A) 223/1984] containing not more than 0.5 part per million of mercury calculated as the metal”;

P.U. (A) 72 13

(f)

by inserting after the item “Narcotic substances, the following: their isomers (whenever the existence of such isomers is possible within the specific chemical designation); their salts; their esters and ethers (whenever the existence of such esters or ethers is possible); the salts of their esters and ethers” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Natalizumab

All preparations”;

(g)

in the item “Natamycin”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Natamycin

All preparations unless exempted

Natamycin when use as food additive”;

(h)

by inserting after the item “Perindopril” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Pertuzumab

All preparations”;

P.U. (A) 72 14

(i)

in the item “Potassium hydroxide”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Potassium hydroxide

12% and over unless exempted

Under 12%, accumulators, batteries or when use as food additive”;

(j)

by inserting after the item “Practolol; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Pralatrexate

All preparations”;

(k)

by inserting after the item “Recombinant-Methionyl Human Granulocyte-colony stimulating factor” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Regorafenib

All preparations”;

P.U. (A) 72 15

(l)

in the item “Sodium hydroxide”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Sodium hydroxide

All preparations for therapeutic or diagnostic use

All preparations containing 12% and over other than those in Part I or exempted and subject to the provisions of Poisons

(Sodium Hydroxide)

Regulations, 1962

[L.N. 145/62]

Under 12%;

Sodium hydroxide when use as food additive”; and

(m)

by inserting after the item “Vecuronium; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Vemurafenib

All preparations”; and

(2)

in the Appendix to the Poisons List—

(a)

in the list of “Antineoplastic agents and Immunosuppressants”—

(i)

by inserting after the item “L-Asparaginase” the item “Axitinib”;

P.U. (A) 72 16

(ii)

by inserting after the item “Mycophenolic acid” the item “Natalizumab”;

(iii)

by inserting after the item “Penciclovir” the following items:

“Pertuzumab

Pralatrexate”;

(iv)

by inserting after the item “Rasburicase” the item “Regorafenib”; and

(v)

by inserting after the item “Trofosfamide” the item “Vemurafenib”.

(b)

in the list of “Vasodilators”, by inserting after the item “Amyl nitrite” the item “Avanafil”; and

(c)

in the list of “Miscellaneous”, by inserting after the items “Anticoagulant substances including heparin and other substances structurally derived from coumarin and phenindione unless specified elsewhere in the List” the item

“Apixaban”.

Made 11 February 2014

[KK(R)608(14); PN(PU2)172/XII]

DATUK SERI DR. S. SUBRAMANIAM

Minister of Health

Common questions

What is PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014?: PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 is Malaysia P.U. (A), cited as P.U. (A) 72 2014, currently marked in force and first recorded in 2014.
Is PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 still in force?: Yes — PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 is currently in force.
When did PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 take effect?: PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 was first recorded in 2014.
How many sections does PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 have?: PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 contains 2 sections.
Where can I read the official version of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014?: The official text of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2014 is published at lom.agc.gov.my.